WisdomTree (WETF) Adopts Poison Pill Following 'Rapid Accumulation' of Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
WisdomTree Adopts Limited Duration Stockholder Rights Plan
March 14, 2022 5:30 AM EDTStockholders to Vote on Rights Plan at 2022 Annual Meeting
NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- WisdomTree Investments, Inc. (WisdomTree or the Company) (NASDAQ: WETF), an exchange-traded fund (ETF) and exchange-traded product (ETP) sponsor and asset manager, today announced that its Board of Directors (the Board) adopted a limited duration stockholder rights plan (the rights plan).
The Board adopted the rights plan in response to the recent rapid accumulations of significant portions of WisdomTree outstanding common stock. It is intended to protect WisdomTree and its stockholders from efforts by a single stockholder or group of... More



